Metabolic Brain Disease

, Volume 32, Issue 4, pp 1311–1321 | Cite as

The analgesic effect of trans-resveratrol is regulated by calcium channels in the hippocampus of mice

  • Weijie Wang
  • Yingcong Yu
  • Jing Li
  • Lin Wang
  • Zhi Li
  • Chong Zhang
  • Linlin Zhen
  • Lianshu Ding
  • Gang Wang
  • Xiaoyang Sun
  • Ying Xu
Original Article
  • 180 Downloads

Abstract

Resveratrol has been widely studied in terms of it’s potential to slow the progression of many diseases. But little is known about the mechanism of action in neuropathic pain. Neuropathic pain is the main type of chronic pain associated with tissue injury. Calcium channels and calcium/caffeine-sensitive pools are associated with analgesic pathway involving neuropathic pain. Our previous study suggested that the antinociceptive effect of resveratrol was involved in Ca2+/calmodulin-dependent signaling in the spinal cord of mice. The aim of this study was to explore the involvement of Ca2+ in analgesic effects of trans-resveratrol in neuropathic pain and signal pathway in hippocampus. Hot plate test was used to assess antinociceptive response when mice were treated with trans-resveratrol alone or in combination with Mk 801, nimodipine, CaCl2, ryanodine or EGTA. The effects of trans-resveratrol and the combination on Ca2+/calmodulin-dependent protein kinase II (CaMKII) and BDNF (brain-derived neurotrophic factor) expression in hippocampus were also investigated. The results showed that trans-resveratrol increased paw withdraw latency in the hot plate test. The effect of resveratrol was enhanced by Mk 801 and nimodipine. Central administration of Ca2+, however, abolished the antinociceptive effects of resveratrol. In contrast, centrally administered EGTA or ryanodine improved trans-resveratrol induced antinociception. There was a significant increase in p-CaMKII and BDNF expression in the hippocampus when resveratrol were combined with Mk 801, nimodipine, ryanodine and EGTA. Administration of CaCl2 blocked changes in p-CaMKII and BDNF levels in the hippocampus. These findings suggest that trans-resveratrol exerts the effects of antinociception through regulation of calcium channels and calcium/caffeine-sensitive pools.

Keywords

Trans-resveratrol Antinociceptive Calcium channels Calcium/caffeine-sensitive pools CaMKII BDNF 

Notes

Acknowledgment

This project was supported by the Natural Science Foundation of Zhejiang Province(NO.LY15H090003)and the Public Applied Research of Zhejiang Province(NO.2016F82SA100042)to Dr. G. Wang. This work was also supported by the National Natural Science Foundation for the Youth (NSFY 81400600) and Zhejiang province key science and technology innovation team (2013TD13) to Dr. YC Yu. The authors do not have financial or personal conflicts of interest associated with this work.

References

  1. Backonja M, Woolf CJ (2010) Future directions in neuropathic pain therapy: closing the translational loop. Oncologist 15:24–29CrossRefPubMedGoogle Scholar
  2. Baron R (2006) Mechanisms of disease: neuropathic pain - a clinical perspective. Nat Clin Pract Neurol 2:95–106CrossRefPubMedGoogle Scholar
  3. Bennett MK, Erondu NE, Kennedy MB (1983) Purification and characterization of a calmodulin-dependent protein kinase that is highly concentrated in brain. J Biol Chem 258:12735–12744PubMedGoogle Scholar
  4. Ben-Sreti MM, Gonzalez JP, Sewell RD (1983) Effects of elevated calcium and calcium antagonists on 6,7-benzomorphan-induced analgesia. Eur J Pharmacol 90:385–391CrossRefPubMedGoogle Scholar
  5. Brüggemann I, Schulz S, Wiborny D, Höllt V (2000) Colocalization of the mu-opioid receptor and calcium/calmodulin-dependent kinase II in distinct pain-processing brain regions. Brain Res Mol Brain Res 85:239–250CrossRefPubMedGoogle Scholar
  6. Carlton SM (2002) Localization of CaMKIIalpha in rat primary sensory neurons: increase in inflammation. Brain Res 947:252–259CrossRefPubMedGoogle Scholar
  7. Chapman DB, Way EL (1982) Modification of endorphine/enkephalin analgesia and stress-induced analgesia by divalent cations, a cation chelator and an ionophore. Br J Pharmacol 75:389–396CrossRefPubMedPubMedCentralGoogle Scholar
  8. Chen JQ, Zhang YQ, Dai J, Luo ZM, Liang SP (2005) Antinociceptive effects of intrathecally administered huwentoxin-I, a selective N-type calcium channel blocker, in the formalin test in conscious rats. Toxicon 45:15–20CrossRefPubMedGoogle Scholar
  9. Del Pozo E, Rouiz-Garcia C, Bayens JM (1990) Analgesic effects of diltiazem and verapamil after central and peripheral administration in the hot-plate test. Gen Pharmacol 21:681–685CrossRefPubMedGoogle Scholar
  10. Eaton MJ, Santiago DI, Dancausse HA, Whittemore SR (1997) Lumbar transplants of immortalized serotonergic neurons alleviates chronic neuropathic pain. Pain 72:59–69CrossRefPubMedGoogle Scholar
  11. Eddy NB, Leimbach D (1953) Synthetic analgesics II Dithienylbutenyland dithienylbutylamines. J Pharmacol Exp Ther 107:385–393PubMedGoogle Scholar
  12. Eisenach JC, Zhang Y, Duflo F (2005) Alpha2-adrenoceptors inhibit the intracellular Ca2+ response to electrical stimulation in normal and injured sensory neurons, with increased inhibition of calcitonin gene-related peptide expressing neurons after injury. Neuroscience 131:187–197CrossRefGoogle Scholar
  13. Evans RC, Morera-Herreras T, Cui Y, Du K, Sheehan T, Kotaleski JH, Venance L, Blackwell KT (2012) The effects of NMDA subunit composition on calcium influx and spike timing-dependent plasticity in striatal medium neruons. PLoS Comput Biol 8:e1002493CrossRefPubMedPubMedCentralGoogle Scholar
  14. Friel DD, Tsien RW (1992) A caffeine- and ryanodine-sensitive Ca2+ store in bullfrog sympathetic neurones modulates effects of Ca2+ entry on [Ca2+]i. J Physiol 450:217–246CrossRefPubMedPubMedCentralGoogle Scholar
  15. Galeotti N, Bartolini A, Ghelardini C (2004) Role of intracellular calcium in acute thermal pain perception. Neuropharmacology 47:935–944CrossRefPubMedGoogle Scholar
  16. Ghosh A, Carnahan J, Greenberg ME (1994) Requirement for BDNF in activity-dependent survival of cortical neurons. Science 263:1618–1623CrossRefPubMedGoogle Scholar
  17. Granados-Soto V, Argüelles CF, Ortiz MI (2002) The peripheral antinociceptive effect of resveratrol is associated with activation of potassium channels. Neuropharmacology 43:917–923CrossRefPubMedGoogle Scholar
  18. Guo ZY, Li CZ, Li XJ, Wang YL, Mattson MP, Lu CB (2013) The developmental regulation of glutamate receptor-mediated calcium signaling inprimary cultured rat hippocampal neurons. Neuroreport 24:492–497CrossRefPubMedGoogle Scholar
  19. Hafeshjani ZK, Karami M, Biglarnia M (2012) Nitric oxide in the hippocampal cortical area interacts with naloxone in inducing pain. Indian J Pharmacol 44:443–447CrossRefPubMedPubMedCentralGoogle Scholar
  20. Haley TJ, McCormick WG (1957) Pharmacological effects produced by interacerebral injections of drugs in the conscious mouse. Br J Pharmacol 12(1):12–15Google Scholar
  21. Han J, Kwon M, Cha M, Tanioka M, Hong SK, Bai SJ, Lee BH (2015) Plasticity-related PKMζ signaling in the insular cortex is involved in the modulation of neuropathic pain after nerve injury. Neural Plast 2015:601767PubMedPubMedCentralGoogle Scholar
  22. Harden RN (2005) Chronic neuropathic pain. Mechanisms, diagnosis, and treatment. Neurologist 11:111–122CrossRefPubMedGoogle Scholar
  23. Harris RA, Loh HH, Way EL (1975) Effects of divalent cations, cation chelators and an ionophore on morphine analgesia and tolerance. J Pharmcol Exp Ther 195:488–498Google Scholar
  24. Heinke B, Balzer E, Sandkuhler J (2004) Pre- and postsynaptic contributions of voltage-dependent Ca2+ channels to nociceptive transmission in rat spinal lamina I neurons. Eur J Neurosci 19:103–111CrossRefPubMedGoogle Scholar
  25. Horiguchi N, Ago Y, Asada K, Kita Y, Hiramatsu N, Takuma K, Matsuda T (2013) Involvement of spinal 5-HT1A receptors in isolation rearing-induced hypoalgesia in mice. Psychopharmacology (Berl) 227:251–261CrossRefGoogle Scholar
  26. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218–220CrossRefPubMedGoogle Scholar
  27. Kakunaga T, Kaneto H, Hano K (1966) Pharmacologic studies on analgesics. VII. Significance of the calcium ion in morphine analgesia. J Pharmacol Exp Ther 153:134–141PubMedGoogle Scholar
  28. Kolarow R, Brigadski T, Lessmann V (2007) Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium calmodulin kinase II signaling and proceeds via delayed fusion pore opening. J Neurosci 27:10350–10364CrossRefPubMedGoogle Scholar
  29. Liang JH, Wang XH, Liu RK, Sun HL, Ye XF, Zheng JW (2003) Buspirone-induced antinociception is mediated by L-type calcium channels and calcium/caffeine-sensitive pools in mice. Psychopharmacology (Berl) 166:276–283CrossRefGoogle Scholar
  30. Lisman J, Schulman H, Cline H (2002) The molecular basis of CaMKII function in synaptic and behavioural memory. Nat Rev Neurosci 3:175–190CrossRefPubMedGoogle Scholar
  31. MacCarrone M, Lorenzon T, Guerrieri P, Agro AF (1999) Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur J Biochem 265:27–34CrossRefPubMedGoogle Scholar
  32. Mahani SE, Motamedi F, Ahmadiani A (2006) Involvement of hypothalamic pituitary adrenal axis on the nifedipine-induced antinociception and tolerance in rats. Pharmacol Biochem Behav 85:422–427CrossRefPubMedGoogle Scholar
  33. da Matta CB, de Souza ET, de Queiroz AC, de Lira DP, de Araújo MV, Cavalcante-Silva LH, de Miranda GE, de Araújo-Júnior JX, Barbosa-Filho JM, de Oliveira Santos BV, Alexandre-Moreira MS (2011) Antinociceptive and anti-inflammatory activity from algae of the genus Caulerpa. Mar Drugs 9:307–318CrossRefPubMedPubMedCentralGoogle Scholar
  34. McPherson PS, Kim YK, Valdivia H, Knudson CM, Takekura H, Franzini-Armstrong C, Coronado R, Campbell KP (1991) The brain ryanodine receptor: a caffeine-sensitive Caclium release channel. Neuron 7:17–25CrossRefPubMedGoogle Scholar
  35. Miranda HF, Pelissier T, Sierralta F (1993) Analgesic effects of intracerebroventricular administration of calcium channel blockers in mice. Gen Pharmacol 24:201–204CrossRefPubMedGoogle Scholar
  36. Mullin GE (2011) Red wine, grapes, and better health-resveratrol. Nutr Clin Pract 26:722–723CrossRefPubMedGoogle Scholar
  37. Ogawa A, Dai Y, Yamanaka H, Iwata K, Niwa H, Noguchi K (2005) Ca(2+)/calmodulin-protein kinase IIalpha in the trigeminal subnucleus caudalis contributes to neuropathic pain following inferior alveolar nerve transection. Exp Neurol 192:310–319CrossRefPubMedGoogle Scholar
  38. Orallo F (2006) Comparative studies of the antioxidant effects of cis- and trans-resveratrol. Curr Med Chem 13:87–98CrossRefPubMedGoogle Scholar
  39. Prado WA (2001) Involvement of calcium in pain and antinociception. Braz J Med Biol Res 34:449–461CrossRefPubMedGoogle Scholar
  40. Rousseau E, Smith JS, Meissner G (1987) Ryanodine modifies conductance and gating behavior of single Ca2+ release channel. Am J Phys 253:C364–C368Google Scholar
  41. Russo GL (2007) Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem Pharmacol 74:533–544CrossRefPubMedGoogle Scholar
  42. Saeki K, Obi I, Ogiku N, Hakamata Y, Matsumoto T (1998) Characterization of brain-type ryanodine receptor permanently expressed in Chinese hamster ovary cells. Life Sci 63:575–588CrossRefPubMedGoogle Scholar
  43. Sałat K, Jakubowska A, Kulig K (2014) Zucapsaicin for the treatment of neuropathic pain. Expert Opin Investig Drugs 23:1433–1440CrossRefPubMedGoogle Scholar
  44. Schmidt WK, Way EL (1980) Hyperalgesic effects of divalent cations and antinociceptive effects of a calcium chelator in naive and morphine-dependent mice. J Pharmacol Exp Ther 212:22–27PubMedGoogle Scholar
  45. Sharma S, Kulkarni SK, Chopra K (2007) Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Fundam Clin Pharmacol 21:89–94CrossRefPubMedGoogle Scholar
  46. Shirahama M, Ushio S, Egashira N, Yamamoto S, Sada H, Masuguchi K, Kawashiri T, Oishi R (2012) Inhibition of Ca2+/calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in rats. Mol Pain 8:26CrossRefPubMedPubMedCentralGoogle Scholar
  47. Siniscalco D, Giordano C, Rossi F, Maione S, de Novellis V (2011) Role of neurotrophins in neuropathic pain. Curr Neuropharmacol 9:523–529CrossRefPubMedPubMedCentralGoogle Scholar
  48. Smith FL, Stevens DL (1995) Calcium modulation of morphine analgesia: role of calcium channels and intracellular pool calcium. J Pharmacol Exp Ther 272:290–299PubMedGoogle Scholar
  49. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto JM, Dannenberg AJ (1998) Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273:21875–21882CrossRefPubMedGoogle Scholar
  50. Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME (1998) Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20:709–726CrossRefPubMedGoogle Scholar
  51. Todorovic SM, Pathirathna S, Meyenburg A, Jevtovic-Todorovic V (2004) Mechanical and thermal anti-nociception in rats after systemic administration of verapamil. Neurosci Lett 360:57–60CrossRefPubMedGoogle Scholar
  52. Venegas H, Schaible H (2000) Effects of antagonists to high threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia. Pain 85:9–18CrossRefGoogle Scholar
  53. Vocci FJ, Welch SP, Dewey WL (1980) Differential effects of divalent cation, cation chelators and an ionophore (A23187) on morphine and dibutyryl guanosine 3′: 5′-cyclic monophosphate antinociception. J Pharmacol Exp Ther 214:463–466PubMedGoogle Scholar
  54. Wang JF, Han SP, Lu Z, Wang XJ, Han JS, Ren MF (1989) Effect of calcium ion on analgesia of opioid peptides. Int J Neurosci 47(3–4):279–285CrossRefPubMedGoogle Scholar
  55. Weiss N, De Waard M (2006) Voltage-dependent calcium channels at the heart of pain perception. Med Sci (Paris) 22:396–404CrossRefGoogle Scholar
  56. Wigestrand MB, Fonnum F, Ivar WS (2012) Subunit-specific modulation of [(3)H]MK-801 binding to NMDA receptors mediated by dopamine receptor ligands in rodent brain. Neurochem Int 61:266–276CrossRefPubMedGoogle Scholar
  57. Wong CH, Wu WH, Zbuzek VK (1998) Hypotension does not alter the antinociceptive effect of nifedipine. Life Sci 63:343–348CrossRefGoogle Scholar
  58. Xu Y, Wang Z, You W, Zhang X, Li S, Barish PA, Vernon MM, Du X, Li G, Pan J, Ogle WO (2010) Antidepressant-like effect of trans-resveratrol: involvement of serotonin and noradrenaline system. Eur Neuropsychopharmacol 20:405–413CrossRefPubMedGoogle Scholar
  59. Yin Q, Lu FF, Zhao Y, Cheng MY, Fan Q, Cui J, Liu L, Cheng W, Yan CD (2013) Resveratrol facilitates pain attenuation in a rat model of neuropathic pain through the activation of spinal Sirt1. Reg Anesth Pain Med 38:93–99CrossRefPubMedGoogle Scholar
  60. Zhao X, Xu Y, Zhao Q, Chen CR, Liu AM, Huang ZL (2012) Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved. Neuropharmacology 62:843–854CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Weijie Wang
    • 1
  • Yingcong Yu
    • 2
  • Jing Li
    • 3
  • Lin Wang
    • 4
  • Zhi Li
    • 5
    • 6
  • Chong Zhang
    • 6
  • Linlin Zhen
    • 5
  • Lianshu Ding
    • 1
  • Gang Wang
    • 4
  • Xiaoyang Sun
    • 1
  • Ying Xu
    • 5
    • 6
  1. 1.Department of Neurosurgery, Huai’an First People’s HospitalNanjing Medical UniversityHuai’anChina
  2. 2.Department of Gastroenterology, Wenzhou People’s HospitalWenzhou No. 3 Clinical Institute affiliated to Wenzhou Medical UniversityWenzhouChina
  3. 3.Department of PharmacyThe Affiliated Hospital of Qingdao UniversityQingdaoChina
  4. 4.Department of Clinical Pharmacy, Hangzhou First People’s HospitalNanjing Medical UniversityHangzhouChina
  5. 5.Department of Pharmaceutical Sciences, School of Pharmacy & Pharmaceutical SciencesThe State University of New York at BuffaloBuffaloUSA
  6. 6.Department of Thyroid Gland and Breast Surgery, Huai’an First People’s HospitalNanjing Medical UniversityHuai’anChina

Personalised recommendations